康柏西普联合玻璃体切除术治疗增生性糖尿病视网膜病变
Zhao Xuejun
【期刊名称】《中华眼外伤职业眼病杂志》 【年(卷),期】2019(041)001
【摘要】目的 探讨玻璃体内注射康柏西普联合玻璃体切除术治疗增生性糖尿病视网膜病变(PDR)的临床效果.方法 回顾性分析2014年5月至2017年4月我院眼科PDR玻璃体切除手术治疗204例(215眼).随机分为两组:对照组,102例(108眼),进行常规玻璃体切除手术;观察组,102例(107眼)在玻璃体切除术前3d行玻璃体内注射康柏西普.术后观察两组治疗效果.结果 术前两组间视力、眼压、并发症及黄斑中心区厚度等差异无统计学意义(P＞0.05).术后两组间视力、眼压、并发症及黄斑中心区厚度等差异有统计学意义(P＜0.05).结论 PDR玻璃体切除手术前应用康柏西普玻璃体内注射可以减少术中及术后出血、减轻黄斑水肿及提高视功能等.%Objective To investigate the clinical efficacy of intravitreal injection of Conbercept combined with vitrectomy in the treatment of proliferative diabetic retinopathy(PDR).Methods The data of 215 eyes 204 cases of PDR from May 2014 to Apr.2017 were analyzed retrospectively.All cases were randomly divided into two groups.The control group,108 eyes of 102 cases,underwent routine vitrectomy;the observation group,107 eyes of 102 cases,received intravitreal injection of Conbercept 3 days before vitrectomy.The efficacy of the two groups was observed after operation.Results The difference in visual acuity,intraocular pressure,complications and central macular thickness
were not statistically significant between the two groups before operation (P ＞ 0.05).The difference in visual acuity,intraocular pressure,complications and macular central thickness were statistically significant between the two groups after operation (P ＜ 0.05).Conclusion lntravitreal injection of Conbercept before vitrectomy can reduce hemorrhage and macular edema during and after operation,and can improve visual function. 【总页数】4页(37-40)
【关键词】康柏西普;玻璃体内注射;玻璃体切除术;糖尿病视网膜病变,增生性;黄斑,中心区,厚度
【作者】Zhao Xuejun
【作者单位】Department of Ophthalmology, Central Hospital of Jiaozuo Coal Industry, Jiaozuo, Henan 454150, China 【正文语种】中文 【中图分类】 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-journal-ocular-trauma-occupational-eye-disease_thesis/0201270500139.html 【相关文献】
1.康柏西普辅助微创玻璃体切除术治疗增生性糖尿病视网膜病变的临床观察 [J], 吴志勇; 姚宜; 闵云花; 陈志义; 刘欣怡; 韩丽荣
2.玻璃体腔内注射康柏西普联合玻璃体切除术治疗增殖性糖尿病视网膜病变的临床效果 [J], 朴天华; 张召弟; 杨岚; 帅天姣
3.玻璃体腔内注射康柏西普联合玻璃体切除术治疗增殖性糖尿病视网膜病变疗效观察 [J], 姚永屿; 夏鸿慧; 范卫; 甄铭伟
4.康柏西普玻璃体腔内注射联合玻璃体切除术治疗增殖性糖尿病视网膜病变的效果观察 [J], 张慧敏
5.雷珠单抗玻璃体注射联合玻璃体切除术对比单纯玻璃体切除术治疗增殖性糖尿病视网膜病变临床分析 [J], 张坚; 张健; 张乐
以上内容为文献基本信息，获取文献全文请下载
康柏西普联合玻璃体切除术治疗增生性糖尿病视网膜病变
